{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:11:51Z","timestamp":1774869111287,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.pnpbp.2006.09.016","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T02:29:44Z","timestamp":1163644184000},"page":"378-382","source":"Crossref","is-referenced-by-count":35,"title":["Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients"],"prefix":"10.1016","volume":"31","author":[{"given":"Michael","family":"Segal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi","family":"Avital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severina","family":"Berstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Derevenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Sandbank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.09.016_bib1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archpsyc.60.6.565","article-title":"Sex differences in the risk of schizophrenia: evidence from meta-analysis","volume":"60","author":"Aleman","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib2","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib3","unstructured":"AxSYM Estradiol assay, (2001) Abbott Laboratories. Diagnostic Division; 1\u20138."},{"key":"10.1016\/j.pnpbp.2006.09.016_bib4","series-title":"Microparticle Enzyme Immunoassay (MEIA) for the quantitative measurement of prolactin in human serum and plasma","author":"AxSYM Prolactin assay-a","year":"1997"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.schres.2004.06.013","article-title":"Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics","volume":"73","author":"Bergemann","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib6","first-page":"12","article-title":"Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease","volume":"27","author":"Cyr","year":"2002","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpsyc.1985.01790260053006","article-title":"Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems","volume":"42","author":"Davis","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/REVNEURO.1994.5.1.27","article-title":"Modulation of brain dopamine transmission by sex steroids","volume":"5","author":"Di Paolo","year":"1994","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(81)90153-9","article-title":"Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors","volume":"17","author":"Di Paolo","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib10","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/0024-3205(82)90684-1","article-title":"Effect of prolactin and estradiol on rat striatal dopamine receptors","volume":"31","author":"Di Paolo","year":"1982","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib11","first-page":"151","article-title":"Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients","volume":"48","author":"Faraone","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02088099","article-title":"Estrogen control of central neurotransmission: effect on mood, mental state, and memory","volume":"16","author":"Fink","year":"1996","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib13","first-page":"389","article-title":"Modulation of dopamine receptor sensitivity by estrogen","volume":"15","author":"Gordon","year":"1980","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0736-5748(00)00017-4","article-title":"Neuroprotective effects of estrogens: potential mechanisms of action","volume":"18","author":"Green","year":"2000","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-1781(90)90026-2","article-title":"Prolactin shifts after neuroleptic withdrawal","volume":"32","author":"Green","year":"1990","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02193758","article-title":"Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission. Evidence from an epidemiological study and from animal experiments","volume":"241","author":"Hafner","year":"1991","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-1781(91)90038-Q","article-title":"An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia","volume":"38","author":"Hafner","year":"1991","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(98)00113-3","article-title":"Depressive symptoms and presynaptic dopamine function in neuroleptic\u2013na\u00efve schizophrenia","volume":"35","author":"Hietala","year":"1999","journal-title":"Schizoph Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0920-9964(03)00176-2","article-title":"Age of menarche and schizophrenia onset in women","volume":"69","author":"Hochman","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.psyneuen.2004.05.010","article-title":"Sex hormones in psychotic men","volume":"30","author":"Huber","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1176\/ajp.151.6.849","article-title":"Outcome and family study of the subtypes of schizophrenia in the west of Ireland","volume":"151","author":"Kendler","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0006-3223(92)90067-A","article-title":"Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients","volume":"32","author":"Kirkpatrick","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000093780","article-title":"Estrogen, cognitive function and negative symptoms in female schizophrenia","volume":"53","author":"Ko","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-9964(99)00139-5","article-title":"Main risk factors for schizophrenia: increased familial loading and pre- and peri-natal complications antagonize the protective effect of estrogen in women","volume":"44","author":"Konnecke","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0920-9964(00)00088-8","article-title":"Estrogen \u2014 a potential treatment for schizophrenia","volume":"48","author":"Kulkarni","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1440-1681.1992.tb00511.x","article-title":"A study of serum prolactin levels in schizophrenia: comparison of males and females","volume":"19","author":"Kuruvilla","year":"1992","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib28","first-page":"221","article-title":"Gender, estrogen, and schizophrenia","volume":"33","author":"Lindamer","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1037\/0022-006X.49.3.438","article-title":"The Maine scale of paranoid and nonparanoid schizophrenia: reliability and validity","volume":"49","author":"Magaro","year":"1981","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0306-4530(94)90017-5","article-title":"Serum gonadal steroid hormones in young schizophrenic patients","volume":"19","author":"Oades","year":"1994","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl 2","key":"10.1016\/j.pnpbp.2006.09.016_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0306-4530(02)00126-9","article-title":"Effects of estrogen on brain development and neuroprotection\u2014implications for negative symptoms in schizophrenia","volume":"28","author":"Rao","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib32","first-page":"22","article-title":"Do estrogens have an antipsychotic action?","volume":"62","author":"Riecher-Rossler","year":"1994","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib33","series-title":"Psychopharmacology: the third generation of progress","first-page":"803","article-title":"Prolactin and schizophrenia","author":"Rubin","year":"1987"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib34","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1096\/fasebj.14.9.1202","article-title":"Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons","volume":"14","author":"Sawada","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2004.02.002","article-title":"Admixture analysis of age at onset in schizophrenia","volume":"71","author":"Schurhoff","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/070674378202700204","article-title":"Gender differences in schizophrenia","volume":"27","author":"Seeman","year":"1982","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.psychres.2004.01.010","article-title":"Serum prolactin levels in unmedicated first-episode and recurrent schizophrenia patients \u2014 a possible marker for the disease's subtypes","volume":"127","author":"Segal","year":"2004","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0920-9964(03)00063-X","article-title":"Sex differences in psychosis: normal or pathological?","volume":"62","author":"Spauwen","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib39","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archpsyc.1992.01820080032005","article-title":"The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description","volume":"49","author":"Spitzer","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib40","first-page":"3","article-title":"Evaluation of serum steroid hormones in schizophrenic patients","volume":"58","author":"Taherianfard","year":"2004","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0006-3223(89)90149-2","article-title":"Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism","volume":"25","author":"Thaker","year":"1989","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.016_bib42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-1781(01)00256-6","article-title":"Lower prolactin bioactivity in unmedicated schizophrenic patients","volume":"102","author":"Warner","year":"2001","journal-title":"Psychiatry Res"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T10:30:03Z","timestamp":1555929003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606003551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0278584606003551"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.09.016","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}